查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1466500

数位治疗市场：按组成部分、按应用划分 - 2024-2030 年全球预测

Digital Therapeutics Market by Component (Devices, Software & Services), Application (Cardiovascular Disease, Central Nervous System Disorder, Chronic Respiratory Disease) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年数位治疗市场规模为64.2亿美元，预计2024年将达80.5亿美元，2030年将达331.6亿美元，复合年增长率为26.42%。

数位治疗，缩写为 DTx，是指数位健康的一个分支，涵盖旨在预防、管理和治疗医学病症和疾病的软体主导的治疗性介入。数位疗法是根据临床证据开发的，并且通常经过严格的监管审查。数位疗法旨在单独使用或与传统疗法结合使用，为患者、医疗保健提供者和付款人提供资料主导的解决方案，以改善患者护理和健康结果。随着慢性病变得更加严重、医疗成本上升以及医疗保健技术进步，数位治疗市场正在不断成长。智慧型手机的普及和远端医疗服务的接受也促进了这项技术的采用。对个人化预防保健解决方案的需求进一步推动了市场成长。然而，市场面临相当大的挑战，包括监管障碍、对患者资料安全的担忧以及数位治疗应用的临床检验需求。面对这些挑战，数位治疗和电子健康记录(EHR) 的整合、人工智慧和机器学习的潜力，为数位治疗市场的创新和未来成长铺平了道路。

主要市场统计
基准年[2023] 64.2亿美元
预测年份 [2024] 80.5亿美元
预测年份 [2030] 331.6亿美元
复合年增长率（%） 26.42%

组件资料分析软体和合规服务的重要性日益增加

数位治疗中包含的设备通常是穿戴式装置、感测器和其他类型的收集患者资料的生物医学硬体。这些设备可以追踪各种健康指标，包括身体活动、睡眠模式和血糖值。偏好倾向于易用性、准确性以及与软体应用程式的无缝整合。软体和服务被认为是数位疗法的核心。此部分由提供治疗性介入的平台、应用程式和专业服务组成。软体和服务的扩充性、互通性、病人参与和资料安全是优先考虑的事项。

应用：数位疗法在需要持续管理和监测的糖尿病和慢性呼吸道疾病的采用率很高。

心血管疾病的数位治疗解决方案通常包括监测心率、血压和心血管健康相关习惯的应用程式。有心臟病史或因遗传因素或生活方式而面临风险的患者对这些解决方案的需求很高。中枢神经系统疾病应用部分包括帕金森氏症、阿兹海默症、忧郁症和过动症等疾病的数位疗法。 DTx 解决方案旨在认知復健、行为治疗和药物管理。在那些寻求非药物干预措施的人中，基于需求的偏好尤其强烈。慢性呼吸道疾病的数位疗法为气喘和慢性阻塞性肺病的管理提供了工具，包括吸入器追踪、症状追踪和环境触发警报。这些是需要持续监测或想要控制疾病恶化的患者的首选。糖尿病数位解决方案专注于血糖值监测、胰岛素剂量追踪和生活方式指导。由于日常管理和监测的需要，糖尿病管理应用程式受到高度青睐。 DTx 的药物依从性应用程式旨在解决患者不按处方服药的挑战。儘管这种需求对于所有患者类别来说都是通用的，但它在慢性病的管理中尤其重要。针对肌肉骨骼疾病的数位疗法提供运动计画、疼痛管理技术和物理治疗指导。它是寻求传统治疗替代或补充治疗的患者的首选。肥胖的数位治疗策略包括个人化营养、身体活动追踪和行为矫正计划。全球肥胖率上升和相关健康风险推动了这一领域的需求。糖尿病前期的数位疗法着重于生活方式干预，以预防第 2 型糖尿病的发展。这些应用对于被诊断患有糖尿病前期的个体来说非常有用，可以减缓或预防疾病进展。戒烟的数位疗法包括戒烟计画、进展追踪和咨询援助。这些工具在试图戒烟的人中很受欢迎，通常是尼古丁替代疗法的补充。

区域洞察

在美洲，数位治疗市场十分强劲，这得益于先进的法律规范、创业投资的大量投资以及 DTx 公司与医疗保健提供者之间不断增长的合作伙伴关係。美国食品药物管理局(FDA) 正在透过处方 DTx 的明确指导和核准为 DTx 产品创造有利的环境，这是将这些解决方案整合到标准医疗保健实践中的重要一步。欧洲市场格局是由多元化的医疗保健格局推动的，强调基于证据的解决方案，并且各国采用不同的方法将 DTx 整合到其医疗保健系统中。德国的数位医疗法案 (DVG) 等倡议允许医生开立数位健康应用程序，是支持性法规环境的一个例子。中东和非洲预计将出现成长，儘管仍处于起步阶段，主要受到基于行动的医疗保健倡议和旨在改善医疗保健服务可近性的合作伙伴关係的推动。亚太地区具有不同的经济、文化和技术准备度，在数位治疗方面展现出巨大的潜力。日本和新加坡等国家处于 DTx 采用的前沿，并在数位医疗创新方面拥有有利的监管途径和措施。在印度和中国等其他地区，智慧型手机普及的不断提高以及政府支持数位健康生态系统的努力正在为 DTx 的扩张创造机会。

FPNV定位矩阵

FPNV 定位矩阵对于评估数位治疗市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对数位治疗市场中供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告对以下几个方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1. 数位治疗市场的市场规模和预测是多少？

2.数位治疗市场预测期内需要考虑投资的产品、细分市场、应用和领域有哪些？

3. 数位治疗市场的技术趋势和法规结构是什么？

4.数位治疗市场主要厂商的市场占有率是多少？

5. 进入数位治疗市场的适当型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病和生活方式相关健康问题的发生率增加
      • 政府推动远端医疗和远距医疗的倡议
      • 结合医疗保健应用程式部署智慧型手机和平板电脑
    • 抑制因素
      • 新兴经济体对数位疗法的认知较低
    • 机会
      • 数位治疗中计算与人工智慧的出现
      • 增加对数位健康业务的资金和投资
    • 任务
      • 资料隐私和安全问题
  • 市场区隔分析
    • 组成部分：资料分析软体和合规服务的重要性日益增加
    • 应用：提高糖尿病和慢性呼吸道疾病数位疗法的采用率，需要持续管理和监控
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章数位治疗市场：按组成部分

  • 装置
  • 软体和服务

第七章数位治疗市场：依应用分类

  • 循环系统疾病
  • 中枢神经系统疾病
  • 慢性呼吸道疾病
  • 糖尿病
  • 用药依从性
  • 肌肉骨骼疾病
  • 肥胖
  • 糖尿病前期
  • 禁止抽烟

第八章美洲数位治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太数位治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲的数位治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • BehaVR 与 Fern Health 合併成立 RealizedCare，推出数位护理管理平台，释放数位治疗的价值
    • Better Therapeutics 宣布推出 AspyreRxTM 治疗成年第 2 型糖尿病患者
    • Lumanity 加入数位治疗联盟
  • 战略分析和建议

第12章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-431752EA4722

[194 Pages Report] The Digital Therapeutics Market size was estimated at USD 6.42 billion in 2023 and expected to reach USD 8.05 billion in 2024, at a CAGR 26.42% to reach USD 33.16 billion by 2030.

Digital therapeutics, abbreviated as DTx, refers to a branch of digital health that encompasses a range of software-driven therapeutic interventions designed to prevent, manage, or treat a medical disorder or disease. Digital therapeutics are developed on the basis of clinical evidence and often undergo rigorous regulatory review. They are intended to be used independently or in conjunction with traditional medical treatments, and they provide patients, healthcare providers, and payers with data-driven, personalized approaches to enhance patient care and health outcomes. The digital therapeutics market is growing with the escalation of chronic diseases, rising healthcare costs, and advancements in healthcare technologies. Increasing smartphone penetration and the acceptance of telehealth services also contribute to the adoption of this technology. The demand for personalized and preventive healthcare solutions further strengthens the market's progress. However, the market faces considerable challenges, including regulatory hurdles, patient data security concerns, and the need for clinical validation of digital therapeutic applications. Amidst these challenges, the integration of digital therapeutics with electronic health records (EHRs) and the potential of AI and machine learning pave the way for innovation and the future growth of the digital therapeutics market.

KEY MARKET STATISTICS
Base Year [2023] USD 6.42 billion
Estimated Year [2024] USD 8.05 billion
Forecast Year [2030] USD 33.16 billion
CAGR (%) 26.42%

Component: Growing significance of data analysis software and compliance services

Devices in digital therapeutics are often wearables, sensors, and other types of biomedical hardware that collect patient data. These devices can track a wide array of health metrics, such as physical activity, sleep patterns, and blood glucose levels. Need-based preference in devices leans towards user-friendliness, accuracy, and seamless integration with software applications. Software & services are seen as the core of digital therapeutics. This segment consists of platforms, applications, and professional services that deliver therapeutic interventions. Preference is given to scalability, interoperability, patient engagement, and data security of software and services.

Application: Higher adoption of digital therapeutics in diabetes and chronic respiratory diseases, requiring continuous management and monitoring

Digital therapeutic solutions aimed at cardiovascular diseases often include applications that monitor heart rate, blood pressure, and cardiovascular health-related habits. Need-based preference for these solutions is high among patients with a history of heart disease and those at risk due to genetic factors or lifestyle. The central nervous system disorder application segment includes digital therapeutics for diseases including Parkinson's, Alzheimer's, depression, and ADHD. DTx solutions here aim at cognitive rehabilitation, behavior therapy, and medication management. Need-based preference is particularly strong among individuals seeking non-pharmacological interventions. Digital therapeutics in chronic respiratory diseases offer tools for asthma and COPD management, including inhaler tracking, symptom tracking, and environmental trigger alerts. These are preferred by patients needing continuous monitoring and those looking to manage disease exacerbations. Digital solutions for diabetes focus on blood glucose monitoring, insulin dosage tracking, and lifestyle coaching. Preference for diabetes management apps is high owing to the need for daily management and monitoring. Medication adherence applications of DTx aim to tackle the challenge of patients not taking their medications as prescribed. This need is ubiquitous across all patient categories but is particularly critical in the management of chronic diseases. Digital therapeutics for musculoskeletal disorders offer exercise programs, pain management techniques, and physical therapy guidance. They are highly preferred by patients seeking remote or supplemental treatment to traditional therapy. Digital therapeutic strategies for obesity include personalized nutrition, physical activity tracking, and behavior modification programs. The need in this segment is driven by the global rise in obesity rates and the associated health risks. Digital therapeutics for prediabetes focus on lifestyle interventions to prevent the onset of type 2 diabetes. These applications are useful for individuals identified as having prediabetes to delay or prevent disease progression. For smoking cessation, digital therapeutics include quit plans, tracking of progress, and counseling support. These tools have a high preference among those trying to quit smoking, often complementing nicotine replacement therapies.

Regional Insights

In the Americas, the market for digital therapeutics is robust, underpinned by progressive regulatory frameworks, significant venture capital investments, and growing partnerships between DTx companies and healthcare providers. The United States Food and Drug Administration (FDA) has been creating a conducive environment for DTx products through clear guidance and approvals for prescription DTx, which are seen as important steps toward integrating these solutions into standard healthcare practices. Europe's digital therapeutics market is marked by a strong emphasis on evidence-based solutions and is driven by a diverse healthcare landscape where countries are adopting various approaches to integrate DTx into their healthcare systems. Initiatives such as Germany's Digital Healthcare Act (DVG), which allows doctors to prescribe digital health applications, exemplify the supportive regulatory environment. The Middle East and Africa, while still at nascent stages, are expected to witness growth, largely propelled by mobile-based health initiatives and partnerships aiming to improve access to healthcare services. The APAC region shows vast potential for digital therapeutics, although the market presents a heterogeneous mix of economic, cultural, and technological readiness. Countries, including Japan and Singapore, are at the forefront of adopting DTx, with favorable regulatory pathways and initiatives for digital health innovation. In other areas, such as India and China, rising smartphone penetration and government initiatives to support digital health ecosystems are creating opportunities for DTx expansion.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Digital Therapeutics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Digital Therapeutics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Digital Therapeutics Market, highlighting leading vendors and their innovative profiles. These include 2morrow Inc., Akili Interactive Labs, Inc., Ayogo Health Inc., Better Therapeutics, Inc., Big Health, Inc., Biofourmis Inc., Canary Health Technologies Inc., Click Therapeutics, Inc., Cognoa, Inc., DarioHealth Corp., Fern Health, Inc., Fitterfly Healthtech Private Limited, Happify, Inc., Headspace Inc., Kaia Health Software Inc., Lark Technologies, Inc., Lumanity Inc., MedRhythms, Noom, Inc., Omada Health Inc., Pear Therapeutics, Inc., Propeller Health by ResMed Corp., SilverCloud by American Well Corporation, Voluntis by AptarGroup, Inc., and Welldoc, Inc..

Market Segmentation & Coverage

This research report categorizes the Digital Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Component
    • Devices
    • Software & Services
  • Application
    • Cardiovascular Disease
    • Central Nervous System Disorder
    • Chronic Respiratory Disease
    • Diabetes
    • Medication Adherence
    • Musculoskeletal Disorder
    • Obesity
    • Prediabetes
    • Smoking Cessation
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Digital Therapeutics Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Digital Therapeutics Market?

3. What are the technology trends and regulatory frameworks in the Digital Therapeutics Market?

4. What is the market share of the leading vendors in the Digital Therapeutics Market?

5. Which modes and strategic moves are suitable for entering the Digital Therapeutics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of chronic diseases and lifestyle-related health issues
      • 5.1.1.2. Government initiatives promoting telehealth and telemedicine
      • 5.1.1.3. Adoption of smartphones and tablets coupled with healthcare apps
    • 5.1.2. Restraints
      • 5.1.2.1. Limited awareness regarding digital therapeutics in developing economies
    • 5.1.3. Opportunities
      • 5.1.3.1. Advent of computing and artificial intelligence in digital therapeutics
      • 5.1.3.2. Rising funding and investments for digital health businesses
    • 5.1.4. Challenges
      • 5.1.4.1. Issues pertaining to data privacy and security
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Component: Growing significance of data analysis software and compliance services
    • 5.2.2. Application: Higher adoption of digital therapeutics in diabetes and chronic respiratory diseases, requiring continuous management and monitoring
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Digital Therapeutics Market, by Component

  • 6.1. Introduction
  • 6.2. Devices
  • 6.3. Software & Services

7. Digital Therapeutics Market, by Application

  • 7.1. Introduction
  • 7.2. Cardiovascular Disease
  • 7.3. Central Nervous System Disorder
  • 7.4. Chronic Respiratory Disease
  • 7.5. Diabetes
  • 7.6. Medication Adherence
  • 7.7. Musculoskeletal Disorder
  • 7.8. Obesity
  • 7.9. Prediabetes
  • 7.10. Smoking Cessation

8. Americas Digital Therapeutics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Digital Therapeutics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Digital Therapeutics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. BehaVR and Fern Health Merge To Form RealizedCare, Launch Digital Care Management Platform to Unlock the Value of Digital Therapeutics
    • 11.3.2. Better Therapeutics Announces Launch of AspyreRxTM to Treat Adults with Type 2 Diabetes
    • 11.3.3. Lumanity Joins The Digital Therapeutics Alliance
  • 11.4. Strategy Analysis & Recommendation

12. Competitive Portfolio

  • 12.1. Key Company Profiles
  • 12.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. DIGITAL THERAPEUTICS MARKET RESEARCH PROCESS
  • FIGURE 2. DIGITAL THERAPEUTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. DIGITAL THERAPEUTICS MARKET DYNAMICS
  • FIGURE 7. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. DIGITAL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 20. DIGITAL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DIGITAL THERAPEUTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CHRONIC RESPIRATORY DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CHRONIC RESPIRATORY DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MEDICATION ADHERENCE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MEDICATION ADHERENCE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MUSCULOSKELETAL DISORDER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MUSCULOSKELETAL DISORDER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PREDIABETES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PREDIABETES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SMOKING CESSATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SMOKING CESSATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 34. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 35. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 36. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 39. ARGENTINA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 40. ARGENTINA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 41. ARGENTINA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 42. ARGENTINA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 43. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 44. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 45. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 46. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 47. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 48. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 49. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 50. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 51. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 52. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 53. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 54. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 55. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 56. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 57. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 58. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 59. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 60. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 68. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 70. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 71. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 72. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 73. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 74. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 75. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 76. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 77. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 78. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 79. INDONESIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 80. INDONESIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 81. INDONESIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 82. INDONESIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 83. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 84. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 85. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 86. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 87. MALAYSIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 88. MALAYSIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 89. MALAYSIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 90. MALAYSIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 91. PHILIPPINES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 92. PHILIPPINES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. PHILIPPINES DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. SINGAPORE DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 96. SINGAPORE DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 97. SINGAPORE DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 98. SINGAPORE DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 99. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 100. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 101. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. TAIWAN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 104. TAIWAN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 105. TAIWAN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 106. TAIWAN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 107. THAILAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 108. THAILAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 109. THAILAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 110. THAILAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 111. VIETNAM DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 112. VIETNAM DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 113. VIETNAM DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 114. VIETNAM DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 121. DENMARK DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 122. DENMARK DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 123. DENMARK DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 124. DENMARK DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 125. EGYPT DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 126. EGYPT DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 127. EGYPT DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 128. EGYPT DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 129. FINLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 130. FINLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 131. FINLAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 132. FINLAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 133. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 134. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 135. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 136. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 137. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 138. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 139. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 140. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 141. ISRAEL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 142. ISRAEL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 143. ISRAEL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 144. ISRAEL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 145. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 146. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 147. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 148. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 149. NETHERLANDS DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 150. NETHERLANDS DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 151. NETHERLANDS DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 152. NETHERLANDS DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 153. NIGERIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 154. NIGERIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 155. NIGERIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 156. NIGERIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 157. NORWAY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 158. NORWAY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 159. NORWAY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 160. NORWAY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 161. POLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 162. POLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 163. POLAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 164. POLAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 165. QATAR DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 166. QATAR DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 167. QATAR DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 168. QATAR DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 169. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 170. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 171. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 172. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 173. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 174. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 175. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 178. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 179. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 180. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 181. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 182. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 183. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 184. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 185. SWEDEN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 186. SWEDEN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 187. SWEDEN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 188. SWEDEN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 189. SWITZERLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 190. SWITZERLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 191. SWITZERLAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 192. SWITZERLAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 193. TURKEY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 194. TURKEY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 195. TURKEY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 196. TURKEY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 197. UNITED ARAB EMIRATES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 198. UNITED ARAB EMIRATES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 199. UNITED ARAB EMIRATES DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 200. UNITED ARAB EMIRATES DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 201. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 202. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 203. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 204. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 205. DIGITAL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 206. DIGITAL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023